Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSC Exosomes for Chronic Cough After COVID-19
NCT05808400Phase 1Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of umbilical cord derived mesenchymal stem cells exosomes in chronic cough and post acute COVID-19 syndrome (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Cough Evaluation Test. Status: unknown.
02
Drugs
umbilical cord derived mesenchymal stem cells exosomes
03
Conditions
chronic coughpost acute COVID-19 syndrome
Beyond the preview
Go deeper on NCT05808400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05808400.